Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company
Home > Investor Relations

Investor Relations

Stock price graph
     

Spectrum Pharmaceuticals is a commercial-stage biotechnology company with a focus in oncology. The Company's strategy is comprised of acquiring and developing a broad and diverse pipeline of late-stage clinical and commercial products; establishing a commercial organization for its approved drugs; continuing to build a team with people who have demonstrated skills, passion, commitment and have a track record of success in its areas of focus; and, leveraging the expertise of partners around the world to assist it in the execution of its strategy.

Spectrum Pharmaceuticals' stock is traded through the Nasdaq Global Market System

Ticker Symbol: SPPI

View all »   RSSRecent Releases

Sep 3, 2015
Spectrum Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw 17th Annual Global Investment Conference on September 10th

Sep 2, 2015
Spectrum Pharmaceuticals Announces Publication of Pivotal EVOMELA™ (melphalan hydrochloride) for Injection Data in the Biology of Blood and Marrow Transplantation Journal

Back to top

Spectrum Pharmaceuticals, Inc. An International Commercial-Stage Biotechnology Company

NASDAQ: SPPI

Price:
6.62
Change:
- 0.40
Day High:
7.35
Day Low:
6.50
Volume:
3,479,700
4:00 PM ET on Sep 2, 2015
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools

Print Email

Search IR